Form 4 for AMPH Amphastar Pharmaceuticals, Inc.
Accepted 2024-11-08 00:00:00 ET · period of report 2024-11-06 · accession 0001415889-24-026465 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-08 | 2024-11-06 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $13.03 | +7,426 | 101.5K | +8% | +$96.8K |
| D | 2024-11-08 | 2024-11-06 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | S - Sale+OE | $52.05 | -7,426 | 94.1K | -7% | -$386.5K |
| D | 2024-11-08 | 2024-11-06 | AMPH | PETERS WILLIAM J | CFO, EVP, Treas, Dir | M - OptEx | $0.00 | -7,426 | 23.7K | -24% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-06 | M | A | 7,426 | $13.03 | 101,529 | D | — | — | |
| 2 | Common | Common Stock | 2024-11-06 | S | D | 7,426 | $52.05 | 94,103 | D | — | — | |
| 3 | Derivative | Employee Stock Option (right to buy) | 2024-11-06 | M | D | 7,426 | $0.00 | 23,674 | D | $13.03 · — to 2030-03-16 | 7,426 Common Stock | (F2) Shares subject to the option are fully vested and immediately exercisable. |